Thomas D. Hart

Quantitative Analysis of Immune Infiltrates in Primary Melanoma

R. Rabadán, Anthea Monod, C. Drake, 2018, Cancer Immunology Research.

The Role of Oncolytic Viruses in the Treatment of Melanoma

T. Enzler, K. Komatsubara, Y. Saenger, 2018, Current Oncology Reports.

Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition

B. Taback, Y. Saenger, R. Gartrell, 2018, Journal of Immunotherapy for Cancer.

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

S. H. van der Burg, C. Melief, Chen Huang, 2019, Journal of Immunotherapy for Cancer.

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

A. Sikora, J. V. Van Ginderachter, D. Laoui, 2019, Journal of Immunotherapy for Cancer.

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

J. Sparano, H. Hibshoosh, Hua Guo, 2020, Frontiers in Oncology.

Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma.

R. Rabadán, Anthea Monod, Andrew X. Chen, 2020, Cancer research.

Characterization and spatial localization of the tumor immune microenvironment in metastatic uveal melanoma.

G. Schwartz, R. Carvajal, B. Taback, 2018 .